Advances in the Management of Early-Stage Triple-Negative Breast Cancer

Advances in the Management of Early-Stage Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with both inter- and intratumor heterogeneity, thought to result in a more aggressive course and worse outcomes. Neoadjuvant therapy (NAT) has become the preferred treatment modality of early-stage TNBC as it allows for the downstagi...

Full description

Bibliographic Details
Main Authors: Prarthna V. Bhardwaj, Yue Wang, Elizabeth Brunk, Philip M. Spanheimer, Yara G. Abdou
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
breast surgery
early-stage TNBC
immunotherapy
neoadjuvant chemotherapy
PARP inhibitors
Online Access:https://www.mdpi.com/1422-0067/24/15/12478

Internet

https://www.mdpi.com/1422-0067/24/15/12478

Similar Items